Completed OBSERVATIONAL NCT00138372

Human Immunity to MSP-1 in Western Kenya

Sponsor: Case Western Reserve University

Conditions Plasmodium Falciparum Malaria

Updated 7 times since 2017 Last updated: Jan 5, 2022 Started: Jul 31, 2004 Primary completion: Sep 30, 2008 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Plasmodium Falciparum Malaria and is currently completed. Case Western Reserve University leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Feb 2022 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Case Western Reserve University
National Institute of Allergy and Infectious Diseases (NIAID)

Data source: Case Western Reserve University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kisumu, Kenya